Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$2.26
+3.2%
C$2.42
C$1.50
C$5.00
C$28.68M2.3063028,120 shs4,037 shs
NVH
Novoheart
C$0.53
+1.9%
C$0.53
C$0.26
C$0.72
C$99.98MN/A33,593 shs23,066 shs
Veresen Inc stock logo
VSN
Veresen
C$0.00
C$11.40
C$19.07
C$5.81BN/A1.30 million shs1.15 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
+3.20%+13.00%-6.61%-24.67%-22.07%
NVH
Novoheart
0.00%0.00%0.00%0.00%0.00%
Veresen Inc stock logo
VSN
Veresen
0.00%0.00%0.00%0.00%0.00%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$2.26
+3.2%
C$2.42
C$1.50
C$5.00
C$28.68M2.3063028,120 shs4,037 shs
NVH
Novoheart
C$0.53
+1.9%
C$0.53
C$0.26
C$0.72
C$99.98MN/A33,593 shs23,066 shs
Veresen Inc stock logo
VSN
Veresen
C$0.00
C$11.40
C$19.07
C$5.81BN/A1.30 million shs1.15 million shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
+3.20%+13.00%-6.61%-24.67%-22.07%
NVH
Novoheart
0.00%0.00%0.00%0.00%0.00%
Veresen Inc stock logo
VSN
Veresen
0.00%0.00%0.00%0.00%0.00%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.00
N/AN/AN/A
NVH
Novoheart
0.00
N/AN/AN/A
Veresen Inc stock logo
VSN
Veresen
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
C$273.38K104.89C$0.06 per share39.00C$0.02 per share92.05
NVH
Novoheart
C$423.50K236.08C$0.07 per share7.46C$0.12 per share4.34
Veresen Inc stock logo
VSN
Veresen
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
-C$12.74M-C$3.47N/AN/A-1,758.62%-185.21%-39.22%N/A
NVH
Novoheart
N/A-C$0.04N/AN/AN/AN/AN/AN/A
Veresen Inc stock logo
VSN
Veresen
N/AN/A0.00N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
N/A4.45%N/AN/AN/A
NVH
Novoheart
N/AN/AN/AN/AN/A
Veresen Inc stock logo
VSN
Veresen
C$1.005.27%N/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
187.90
5.63
1.71
NVH
Novoheart
27.62
6.13
6.05
Veresen Inc stock logo
VSN
Veresen
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
0.05%
NVH
Novoheart
N/A
Veresen Inc stock logo
VSN
Veresen
N/A

Insider Ownership

CompanyInsider Ownership
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
28.06%
NVH
Novoheart
N/A
Veresen Inc stock logo
VSN
Veresen
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Burcon NutraScience Co. stock logo
BU
Burcon NutraScience
2012.69 millionN/ANot Optionable
NVH
Novoheart
N/A188.64 millionN/ANot Optionable
Veresen Inc stock logo
VSN
Veresen
147,000314.00 millionN/ANot Optionable

Recent News About These Companies

Veresen Inc. Stock Price History
BBC Sounds - Assignment - Available Episodes

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Burcon NutraScience stock logo

Burcon NutraScience TSE:BU

C$2.26 +0.07 (+3.20%)
As of 10/16/2025 03:59 PM Eastern

Burcon is a global technology leader in the development of plant-based proteins. With over 285 issued patents and more than 250 additional patent applications, that have been developed over a span of more than twenty years, Burcon has grown an extensive portfolio of composition, application, and process patents covering novel plant-based proteins derived from pea, canola, soy, hemp, sunflower seed and more. In 2019, Merit Functional Foods Corporation was established in a joint venture by Burcon and three veteran food industry executives. Merit Foods is building a state-of-the-art protein production facility in Manitoba, Canada, where it will produce, under license, Burcon's novel pea and canola protein ingredients.

Novoheart CVE:NVH

C$0.53 +0.01 (+1.92%)
As of 11/20/2020

Novoheart Holdings Inc. operates as a stem cell biotechnology company in the United States. The company offers an array of next-generation human heart tissue prototypes. It provides MyHeart platform products, including human pluripotent stem cell-derived cardiomyocytes, human ventricular cardiac anisotropic sheet assays, and human ventricular cardiac tissue strips assays. The company also offers screening and phenotyping services; and consultation services, including mapping and designing preclinical studies that involve human embryonic or induced pluripotent stem cell-derived cardiomyocytes, prototyping custom bioreactor designs, and developing custom software for streamlining of screening platforms and analysis of acquired data. Novoheart Holdings Inc. has a collaboration with AstraZeneca to develop human-specific in vitro functional model of heart failure with preserved ejection fraction. The company is based in Vancouver, Canada.

Veresen stock logo

Veresen TSE:VSN

Veresen Inc is a Canada-based energy infrastructure company that owns and operates energy infrastructure assets across North America. The Company is engaged in three principal businesses: a pipeline transportation business consists of interests in the Alliance Pipeline, the Ruby Pipeline and the Alberta Ethane Gathering System (AEGS); a midstream business, which includes a partnership interest in Veresen Midstream Limited Partnership, which owns assets in western Canada, and an ownership interest in Aux Sable, which owns a natural gas liquids (NGL) extraction facility near Chicago, and other natural gas and NGL processing energy infrastructure, and a power business consists of a portfolio of assets in Canada. The Company's segments include Pipelines, Midstream, Power and Corporate. Alliance Pipeline owns and manages an integrated, high-pressure natural gas and NGL pipeline. Ruby Pipeline is a natural gas transmission system. AEGS is an integrated pipeline system.